Effect of SonoVue on the synovial membrane in rabbit knees

J Ultrasound Med. 2011 Sep;30(9):1241-6. doi: 10.7863/jum.2011.30.9.1241.

Abstract

Objectives: The purpose of this study was to evaluate the effect of intra-articular injection of SonoVue (sulfur hexafluoride with a phospholipid shell; Bracco SpA, Milan, Italy) on the synovial membrane in an animal model.

Methods: Twenty-one New Zealand White rabbits (42 knees) were used in this study. We injected the knees with normal saline (saline group; n = 21) and SonoVue (SonoVue group; n = 21). A histologic examination of the knees was performed out at 3 and 12 hours and 3, 7, 15, 30, and 45 days after injection. Four histologic parameters (synovial hyperplasia, synovial stroma, vascular dilatation, and inflammatory infiltrates) were graded separately.

Results: We found no significant differences in this study for synovial hyperplasia, vascular dilatation, or inflammatory infiltrates between the saline and SonoVue groups. A significant difference was only observed for synovial stroma (P < .05), and most of the histologic changes were mild in the saline group and moderate in the SonoVue group. The histologic changes observed in this study are considered transitory and reversible.

Conclusions: The results suggest that intra-articular injection of SonoVue is a safe procedure.

MeSH terms

  • Animals
  • Chi-Square Distribution
  • Contrast Media / administration & dosage
  • Contrast Media / pharmacology*
  • Injections, Intra-Articular
  • Knee Joint / diagnostic imaging*
  • Male
  • Phospholipids / administration & dosage
  • Phospholipids / pharmacology*
  • Rabbits
  • Sulfur Hexafluoride / administration & dosage
  • Sulfur Hexafluoride / pharmacology*
  • Synovial Membrane / diagnostic imaging*
  • Synovial Membrane / drug effects*
  • Ultrasonography

Substances

  • Contrast Media
  • Phospholipids
  • contrast agent BR1
  • Sulfur Hexafluoride